On September 19–20, 2025, the 6th National Otorhinolaryngology Scientific Conference took place at Hanoi Medical University, gathering leading professors and physicians from across Vietnam. The event was not only an opportunity to update valuable medical knowledge but also a chance for LiveSpo to reaffirm its commitment to the ENT field with the mission “A Future Without Antibiotics.”
Within the framework of the conference, participants attended a series of in-depth scientific sessions. Notably, a presentation by a leading expert highlighted clinical research on ENT treatment solutions, including LiveSpo® NAVAX nasal spray probiotics. Conducted across major hospitals in Vietnam and published in Nature Portfolio, the studies demonstrated that LiveSpo® NAVAX:
- Reduced influenza viral load >400-fold within 2 days
- Reduced RSV viral load >600-fold within 3 days
- Shortened influenza treatment time by 40%
- Reduced antibiotic use for RSV pneumonia by 14%
Importantly, the trials confirmed the product’s safety, with no adverse events reported.
As the Diamond Sponsor, LiveSpo made a notable impact at the conference. Its product showcase attracted strong interest from attending physicians and specialists. LiveSpo also shared details of its four clinical publications on Nature Portfolio, enabling medical professionals to explore the pioneering role of probiotic spores in respiratory care, while broadening perspectives and introducing new approaches to clinical practice.
The conference not only delivered valuable scientific updates but also created opportunities for ENT doctors nationwide to meet, exchange knowledge, and enhance professional expertise—ultimately contributing to improved healthcare quality and better protection of community health.
Looking ahead, LiveSpo remains committed to accompanying national scientific events, spreading its mission of “A Future Without Antibiotics” and introducing innovative probiotic spore-based solutions to the medical community.
